| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | ARGOS VISION INC | 2242 W HARRISON ST STE 201 | CHICAGO | IL | 60612-3515 | COOK | USA | R43EY033589 | Dual Targeting Mitochondria and GPCR in Retinal Protection | 000 | 1 | NIH | 7/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | ARGOS VISION INC. | 2242 W HARRISON ST #201 | CHICAGO | IL | 60612-3515 | COOK | USA | R43EY033589 | Dual Targeting Mitochondria and GPCR in Retinal Protection | 000 | 1 | NIH | 11/2/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $255,710 ) |
| | 2022 | 2022 | ARGOS VISION INC. | 2242 W HARRISON ST #201 | CHICAGO | IL | 60612-3515 | COOK | USA | R43EY033589 | Dual Targeting Mitochondria and GPCR in Retinal Protection | 000 | 1 | NIH | 8/17/2022 | $255,710 |
|
|
